Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Podcast

Get "Totally Clinical" With Teckro's New Industry Podcast - Now on Spotify, Apple, and Google


Teckro, creator of the only clinical trial platform that facilitates collaboration between and among stakeholders, today announced the launch of the Totally Clinical: Trial Triumphs & Rad Trends podcast. The series provides a medium for diverse stakeholders in the clinical trial ecosystem to engage in conversation; inspiring new ways to design, deliver, and improve participation.

To promote the new podcast series, Teckro worked with award-winning actor John C. McGinley. Known as Dr. Perry Cox in the hit television series Scrubs, McGinley stars in a video introducing Totally Clinical.

Totally Clinical episodes cover a variety of topics, ranging from field research perspectives and patient experiences, to drug development advances and technology trends. Gary Hughes, Teckro co-founder and CEO, kicks off the series by talking about operating for the greater good and what it means to be a mission-driven company in the 21st Century.

"Teckro is already the hub for effective communication; connecting stakeholders despite the complex, distributed, and often siloed nature of clinical trials," says Hughes. "Now with the introduction of the Totally Clinical podcast, we are broadening our ambition to engage even more stakeholders in conversations; advancing clinical research and expanding awareness of clinical trials as an option for best possible care."

Other topics include:

"Every initiative that gets people talking is a step forward," says Dr. Zajchowski, "but the Totally Clinical podcast series is also a chance for non-profit organizations to reach other audiences. It allows us to engage in conversations that might accelerate research for treatments and drugs that improve outcomes and survival." 

The Totally Clinical: Trial Triumphs & Rad Trends podcast is available ad-free on Spotify, Apple, and Google. If you are interested in submitting a topic for consideration, contact us.

About Teckro   

Recognized as one of the fastest growing clinical trial start-ups, Teckro transforms the study protocol into a hub of communication and collaboration. It's a digital platform that connects all study stakeholders with the knowledge they need when they need it. Thousands of investigators and more than 23,000 sites around the world rely on Teckro to execute clinical trials. Teckro works with emerging biotech and global pharmaceutical organizations, including 12 out of the Top 20 companies. Teckro supports all therapeutic areas, all phases, and any trial format including traditional in-clinic, decentralized clinical trials, or a hybrid approach.

More Information 


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: